SPG Healthcare Case Study
Implant Manufacturer
Realigning Global Pricing Strategy Across Subsidiary Markets
Overview
A leading orthopedic implant manufacturer sought to transform its pricing strategy and governance model across eight key subsidiary markets — including the U.S., Japan, Australia, the U.K., Germany, Switzerland, Italy, and France.
As the company expanded globally, it needed to move from a historically reactive, relationship-based pricing approach to a strategic, data-driven framework that aligned corporate profitability with local market realities.
Challenge
The company faced several challenges across its international network:
- Lack of alignment between corporate pricing policy and subsidiary-level decisions
- Inconsistent discounting practices and legacy pricing arrangements
- Complex product structures where multiple components combined into a single implant system
- Custom-made product pricing and consignment models that lacked profitability visibility
- Limited insight into where margin leakage and “money on the table” existed
To ensure sustainable growth, the company sought to establish a unified pricing corridor, clear rules for discounting, and a centralized “to-be” pricing process supported by stakeholder engagement across all regions.
Approach
We implemented a multi-phase Global Pricing Transformation Program grounded in data, collaboration, and local market insight.
- Conducted interviews with corporate and subsidiary leadership to identify key pain points and pricing behaviors
- Performed internal data audits on sales revenue, product mix, and discount structures
- Reviewed custom-made and consignment models to evaluate their profitability impact
- Partnered with eight General Managers and finance teams to validate hypotheses and define market-specific priorities
Solution
Our team developed a comprehensive pricing strategy methodology integrating analytical rigor with organizational alignment.
- Executed a Waterfall Analysis to quantify true cost-to-serve by country and channel
- Designed market-specific pricing corridors for core implant components and high-value custom parts
- Defined rules and guidelines for discounting by country and subsidiary type
- Created differential value propositions by segment, highlighting premium vs. commodity offerings
- Delivered a future-state (“to-be”) pricing framework combining centralized governance with local market flexibility
Results
- Identified significant margin recovery and revenue uplift opportunities across subsidiaries
- Established standardized pricing governance and decision-making tools for key stakeholders
- Improved visibility into profitability by product, customer, and region
- Delivered a formal strategic pricing roadmap and methodology to guide ongoing pricing decisions
- Enabled the company to adopt a proactive, strategic pricing mindset across its global network
Impact
The engagement equipped the organization with a scalable, transparent, and value-based pricing structure.
By aligning local market expertise with centralized oversight, the company reduced pricing inconsistencies, strengthened profitability, and built a foundation for sustainable growth across its global operations.
Aligning Strategy. Empowering Growth
We help global healthcare and MedTech companies design pricing frameworks that balance local market realities with corporate objectives.
Let’s build a smarter, more aligned pricing system for your international growth.